Worldwide Biologics Market to Witness a Pronounce Growth by 2027

“Market Research Future”
This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the global Biologics Market over the forecast period.

The Global Biologics Market report titled “Biologics Market Research Report-Forecast to 2027″ is a specialist investigation report by Market Research Future includes broad essential research alongside the definite examination of subjective and additionally quantitative perspectives by different industry specialists, key sentiment pioneers to pick up a more profound understanding of the market and industry execution. 

Market Research Future published new report, titled “Biologics Market -Research Report: Global Forecast till 2027”.

Competition in the Global Biologics Market and are profiled in MRFR Analysis. “Global Biologics Market by Manufacturers, Countries, Type and Application, Forecast to 2027 Report “Provides In-Depth Analysis Of Parent Market Trends, Macro-Economic Indicators And Governing Factors Along With Market Attractiveness As Per Segments.

Global Biologics Market – Overview:

Biologics are compounds of pharmaceutical importance such as sugars, proteins, and nucleic acids or complex combinations of these substances, or they can be  living entities by themselves which are inclusive of such cells and tissues. Biologics can be isolated from natural sources including human beings, animal, or microorganism, and may be produced by biotechnological procedures through various cutting-edge technologies. Gene-based and cellular biologics are at the forefront of various biomedical research, and can be used as novel strategy for the treatment of a variety of medical conditions. Rising prevalence of different chronic and acute diseases such as cancer, diabetes, besides others, and increasing demand for the better and biological therapy drives the growth of the market during the forecast period. According to the National Cancer Institute in 2016, approximately, 1,685,210 new cases of cancer were diagnosed in the U.S. and 595,690 people died from the disease. Moreover, it was estimated that the national expenditures for cancer care in the U.S. could reach from USD 125 billion in 2010 to USD 156 billion by 2020. Additionally, growing geriatric population and rising healthcare expenditure boosts the market growth. According to the Johns Hopkins University, for people who are over the age of 65 years, there is an 11-fold increased incidence of developing cancer as compared to younger individuals. Moreover, according to the Population Reference Bureau, the number of the Americans who age 65 or more is projected to reach over 98 million by 2060. However, the market growth can be restricted by the long term approval time and high cost for environmental condition management.

The global biologics market is growing with a sound pace. According to a recent study report published by the Market Research Future, the Global Biologics Market is booming and expected to gain prominence over the forecast period. The market is projected to demonstrate a sound growth by 2027, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2027).


Global Biologics Market – Competitive Analysis:

AbbVie, Amgen, Biogen Idec, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline plc., Johnson and Johnson, Merck and Co., Merck KGaA, Novartis, Pfizer, F. Hoffmann-La Roche Ltd, and Sanofi are some of the prominent players at the forefront of competition in the Global Biologics Market and are profiled in MRFR Analysis.
Characterized by the presence of several well-established and small players, the global biologics market appears to be highly competitive and fragmented. International players are expanding their footprint in the developing economy, making it difficult for regional vendors to compete with them, especially in terms of features such as product portfolios, quality, and pricing.  The market is witnessing intensified competition which is expected to get more intensified further during the forecast period. The intense competition prevalent in the market dictates the consolidation among marketers.

Well established players incorporate acquisition, collaboration, partnership, expansion, and product launch in order to gain competitive advantage in this market and to maintain their market position.

Merck KGaA is one of the prominent players in the Global Biologics Market and is headquartered in Darmstadt, Germany. In January 2017, the company acquired acquired BioControl Systems Inc., a global leader in food safety testing. The acquisition opened growth opportunities for Merck in the food and beverage space; particularly in the U.S.

In August 2016, FDA approved Pfizer’s TROXYCA ER extended-release capsules CII for pain management. This drug is used for abuse-deterrent properties for the management of pain and will help Pfizer to improve their goodwill and sales with this new product

In April 2017, F. Hoffmann-La Roche Ltd. received 510(k) clearance from the U.S. FDA for the CINtec Histology test. This test is the only clinically validated p16 biomarker test. The CINtec Histology test will help physicians make informed decisions as to the best course of care for patients with high-grade pre-cancerous cervical disease.

Global Biologics Market – Regional Analysis:

Geographically, the North America has the largest biologic drug market. Due to increasing prevalence of diseases like Cancer and diabetes in the North America is the major factor for the growth of the market. North America is followed by Europe in biologic market. Asia Pacific is the fastest growing region for biologic market. Biologic market growth of Asia Pacific is majorly driven by Japan, China and India. Beside this a huge population base in this region has provided a fuel for the growth of the market. Middle East and Africa has the least biologic market.

World Biologics Market – Segments:

The World Biologics Market research report is segmented in to 3 key dynamics for the convenience of the report and enhanced understanding;

Segmentation on the basis of Product Type: Comprises vaccines, blood and blood products, allergenic extracts, human cells and tissues, proteins and others.

Segmentation by Application: Comprises Rheumatoid arthritis, renal failure, Anemia, Cancer, Diabetes and others

Segmentation by Source: Comprises Humans, Avian Cell Culture, Yeast, Bacteria, Insects Cell Culture, Transgenics and others



About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
City: Pune
State: Maharashtra
Country: India